FDA questions strength of Johnson & Johnson booster shot data
Oct 13, 2021
The agency says a key test used by the company to measure immune response from booster shot six months after the original shot was likely not sensitive enough.
Immune response may vary with choice of COVID-19 booster
Dec 16, 2021
All seven vaccines tested boosted immunity following two doses of ChAdOx1 nCoV-19; six of seven did so following two doses of BNT162b2.
Scientists spot clues to why omicron infections are milder
Jan 03, 2022
More than a dozen research groups have been observing the omicron variant in lab settings using animals this past month.
Trials show promise for intravitreal faricimab in retinal disease
Feb 02, 2022
Faricimab was noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration and diabetic macular edema.
FDA panel to again weigh merit of decongestant that many call useless
Mar 06, 2023
The agency’s Nonprescription Drugs Advisory Committee will meet in April to consider the effectiveness of the oral version of phenylephrine.
About 100,000 US nurses left workforce during pandemic
Apr 14, 2023
The results of a new survey lay bare the pandemic’s effect on nursing.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
Biden administration pushes for rule wiping medical debt from credit reports
Jun 12, 2024
In an effort to keep medical debt from destroying credit scores, the Biden administration announced Tuesday that it is moving ahead with a proposal that would remove healthcare bills from consideration...
Minimally processed red meat can work in weight loss diet with diabetes
Sep 14, 2023
A high-protein, lean beef diet achieved similar weight loss and glucose control as a normal-protein diet with no red meat.
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.